XML 44 R31.htm IDEA: XBRL DOCUMENT v3.23.1
Equity Incentive Plans (Tables)
 12 Months Ended
Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Restricted Stock Units Activity

A summary of the RSUs awarded to employees, directors and consultants under the 2017 Equity Plan during the years ended December 31, 2022 and 2021 are presented in the table below:

 

   Number of Units   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value 
             
Outstanding, December 31, 2020   50,333   $19.50   $     - 
Granted   -    -   $- 
Vested and settled with share issuance   (45,000)  $18.15   $- 
Forfeited/canceled   (5,333)  $23.10   $- 
Outstanding, December 31, 2021   -   $-   $- 
Granted   6,734   $7.42   $- 
Vested and settled with share issuance   (3,367)  $7.42   $- 
Forfeited/canceled   -   $-   $- 
Outstanding, December 31, 2022   3,367   $7.42   $- 
2017 and 2021 Equity Plan [Member] | Employees And Consultants [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the stock options granted to employees and consultants under the 2017 Equity Plan and the 2021 Equity Incentive Plan during the years ended December 31, 2022 and 2021 are presented in the table below:

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value 
                 
Outstanding, December 31, 2020   95,007   $12.45    7.1   $     - 
Granted   65,508   $9.00    10.0   $- 
Exercised   -   $-    -   $- 
Forfeited   (2,341)  $16.83    7.0   $- 
Expired   -   $-    -   $- 
Outstanding, December 31, 2021   158,174   $10.99    7.6   $- 
Granted   53,960   $2.90    9.2   $- 
Exercised   -   $-    -   $- 
Forfeited   (20,061)  $8.85    8.6   $- 
Expired   -   $-    -   $- 
Outstanding, December 31, 2022   192,073   $8.94    7.6   $- 
Exercisable, December 31, 2022   148,227   $9.86    7.2   $- 
Summary of Non-vested Non-qualified Stock Option Activity

A summary of non-vested stock options activity for employees and consultants under the 2017 Equity Plan and the 2021 Equity Plan for the years ended December 31, 2022 and 2021 are presented in the table below:

 

   Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                 
Nonvested, December 31, 2020   -   $-   $    -   $- 
Granted   65,508   $8.85   $-   $575,711 
Vested   (23,662)  $10.65   $-   $(252,571)
Forfeited   -   $-   $-   $- 
Expired   -   $-   $-   $- 
Nonvested, December 31, 2021   41,846   $7.65   $-   $320,122 
Granted   53,960   $2.86   $-   $154,555 
Vested   (36,960)  $2.68   $-   $- 
Forfeited   (15,000)  $8.52   $-   $- 
Expired   -   $-   $-   $- 
Nonvested, December 31, 2022   43,846   $5.65   $-   $247,739 
2017 and 2021 Equity Plan [Member] | Directors [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Schedule of Stock Option Activity

A summary of the non-qualified stock options granted to directors under the 2017 Equity Plan and 2021 Equity Plan during the years ended December 31, 2022 and 2021 are presented in the table below:

 

 

   Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term   Aggregate Intrinsic Value ($000) 
                 
Outstanding, December 31, 2020   49,333   $10.05    4.5   $        - 
Granted   1,539   $9.75    10.0   $- 
Exercised   -    -    -   $- 
Forfeited/Cancelled   -    -    -   $- 
Expired   -    -    -   $- 
Outstanding, December 31, 2021   50,872   $10.02    6.6   $- 
Granted   6,250   $4.80    9.0   $- 
Exercised   -    -    -   $- 
Forfeited/Cancelled   -    -    -   $- 
Expired   -    -    -   $- 
Outstanding, December 31, 2022   57,122   $9.44    6.0   $- 
Exercisable, December 31, 2022   57,122   $9.44    6.0   $- 
Summary of Non-vested Non-qualified Stock Option Activity

A summary of non-vested non-qualified stock options activity for directors under the 2017 Equity Plan and the 2021 Equity Plan for the years ended December 31, 2022 and 2021 are presented in the table below:

 

   Number of Options   Weighted Average Grant-Date Fair Value   Aggregate Intrinsic Value   Grant-Date Fair Value 
                 
Nonvested, December 31, 2020   6,666   $4.35   $3,400   $29,000 
Granted   1,539   $9.75    -   $15,000 
Vested   (8,205)  $5.40   $4,431   $(44,000)
Forfeited   -    -    -   $- 
Expired   -    -    -   $- 
Nonvested, December 31, 2021   -    -    -   $- 
Granted   6,250   $4.75   $-   $29,656 
Vested   (6,250)  $4.75   $-   $- 
Forfeited   -    -    -   $- 
Expired   -    -    -   $- 
Nonvested, December 31, 2022   -        $-   $-